Skip to content
Wenlo
Sign in
← Markets

Summit Therapeutics Inc.

Manmeet Singh Soni (COO and CFO) reports SMMT insider transactions

4SMMTFiled Nov 16, 2026, 2:49 PM ET· Period Nov 16, 2026

About this filing

Summit Therapeutics Inc. (SMMT) filed Form 4 (insider transaction) with the SEC on Nov 16, 2026. Form 4 reports a company insider’s trades in the company’s shares.

Key facts

Insider
Manmeet Singh Soni · COO and CFO, Director
DateTransactionSharesPriceValueHeld afterOwnership
Nov 16, 2026M · exercise or conversion of a derivativeFootnotes F1, F2+100,000$1.37$137,000.003,224,375Direct
Nov 16, 2026M · exercise or conversion of a derivativeStock Option (right to buy)Footnotes F1, F3−100,000$0.00$0.00100,000Direct
Footnotes
  1. F1 On November 16, 2026, the Reporting Person exercised an option to purchase 100,000 shares of the Issuer's common stock at an exercise price of $1.37 per share.
  2. F2 Holdings include shares previously acquired through exempt transactions pursuant to the Issuer's employee stock purchase plan.
  3. F3 The option was granted on December 23, 2019. The shares underlying the option vested in four equal annual installments, with the first such installment beginning on December 23, 2020.

More SMMT filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.